Abbott Laboratories CDR

Abbott Laboratories CDR is a financial instrument representing a Certificate of Deposit Receipt, which serves as a proxy for shares in Abbott Laboratories, a leading global healthcare company. The primary function of this asset is to offer investors exposure to Abbott Laboratories’ equity in markets outside its home country, making it accessible to international investors who prefer to transact in their local market and currency. Abbott Laboratories is recognized for its diversified operations across sectors such as pharmaceuticals, diagnostics, nutrition, and medical devices. Its products and innovations have a significant presence in global healthcare, ranging from generic medicines and diagnostics equipment to nutritional supplements and advanced medical devices. The CDR structure enables broader international participation and portfolio diversification, allowing investors to benefit from the performance of this major healthcare provider while operating within the regulatory and settlement frameworks of the domestic exchange where the CDR is listed.